Clinical management of renal transplant patients with hepatitis C virus infection treated with cyclosporine or tacrolimus.
Latorre
A
A
Biochemical and Nephrology Department, H 12 De Octubre, Madrid, Spain.
Morales
E
E
Gonzalez
E
E
Herrero
J C
JC
Ortiz
M
M
Sierra
P
P
Dominguez-Gil
B
B
Torres
A
A
Munoz
M A
MA
Andres
A
A
Manzanares
C
C
Morales
J M
JM
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D016572:Cyclosporine / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006526:Hepatitis C / Q000453:epidemiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008111:Liver Function Tests; D008875:Middle Aged; D011183:Postoperative Complications; D012189:Retrospective Studies; D016559:Tacrolimus / Q000493:pharmacokinetics / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D016559:Tacrolimus